Author

G. Fromont-Hankard

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Approach:deep learning· 1 Approach:experimental assay· 1 Organism:human· 1 Assay:scRNA-seq· 1

Frequent Co-Authors

A. Robert· 2 shared C. Vandier· 2 shared D. Crottes· 2 shared M. Gueguinou· 2 shared A. Bura· 1 shared A. Girault· 1 shared A. J. Garcia-Saez· 1 shared A. Le Pape· 1 shared

Activity by Year

2022-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 37 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

A. Robert

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologybioRxivJan 14, 2024

Investigation of the heterogeneity of cancer cells using single cell calcium profiling.

A. Bura, C. Caussette, M. Gueguinou…·D. Crottes

This study uses single cell calcium profiling combined with machine learning to analyze Ca2+ signature heterogeneity in cancer cells and their remodeling during resistance and cell interactions.

DOI 10.1186/s12964-025-02417-3

scRNA-seqdeep learning

𝕏 PostBluesky

Cancer BiologybioRxivJan 18, 2022

Curcumin and NCLX Inhibitors Share Anti-Tumoral Mechanisms in Microsatellite-Instability-Driven Colorectal Cancer

M. Gueguinou, S. Ibrahim, J. Bourgeais…·T. Lecomte

This study identifies NCLX as a therapeutic target in MSI-driven CRC, showing that curcumin and NCLX inhibitors induce anti-tumoral effects through mitochondrial calcium overload and apoptosis.

DOI 10.1007/s00018-022-04311-4

humanbulk RNA-seq

𝕏 PostBluesky